Johnson & Johnson’s Price Target Boosted at Citigroup (JNJ)
Healthcare products giant Johnson & Johnson( JNJ ) on Monday saw its price target raised by analysts at Citigroup.
The firm said it now expects JNJ shares to rach $70, which represents an expected 10% upside to the stock's Friday closing price of $63.57.
Citigroup also reiterated its "Buy" rating on the stock, citing improving current credit trends.
Johnson & Johnson shares were mostly flat in premarket trading Monday.
The Bottom Line
We have been recommending shares of JNJ since Oct.8, 2009, when the stock was trading at $60.71. The company has a 3.40% dividend yield, based on Friday's closing stock price of $63.57.
Johnson & Johnson( JNJ ) is a "Recommended" dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.